mci 9038 has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansara, AJ; Arif, S; Warhurst, RD | 1 |
| Boyle, DA; Choi, YM; Cox, DS; Gobburu, JV; Hossain, M; Madabushi, R; Patel, BR; Young, G | 1 |
| Akita, N; Asanuma, K; Asanuma, Y; Hayashi, T; Matsumine, A; Okamoto, T; Sudo, A; Uchida, A; Wakabayashi, H; Yoshikawa, T | 1 |
| Baillie, GM; Hursting, MJ; McCollum, DA; Rice, L | 1 |
4 other study(ies) available for mci 9038 and Body Weight
| Article | Year |
|---|---|
Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Body Weight; Dose-Response Relationship, Drug; Female; Heparin; Humans; Male; Middle Aged; Nomograms; Pipecolic Acids; Prospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2009 |
Pharmacokinetic and pharmacodynamic basis for effective argatroban dosing in pediatrics.
Topics: Adolescent; Arginine; Bilirubin; Body Weight; Child; Child, Preschool; Computer Simulation; Dose-Response Relationship, Drug; Female; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Models, Biological; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides | 2011 |
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
Topics: Animals; Antithrombins; Arginine; Body Weight; Bone Neoplasms; Breast Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Mice; Pipecolic Acids; Sulfonamides; Thrombin; Thromboplastin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2013 |
Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Body Weight; Female; Heparin; Humans; Male; Obesity; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2007 |